JB Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) — Market Cap & Net Worth
Market Cap & Net Worth: JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
JB Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) has a market capitalization of $3.81 Billion (Rs352.07 Billion) as of June 17, 2026. Listed on the NSE stock exchange, this India-based company holds position #4342 globally and #185 in its home market, demonstrating a 0.92% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying JB Chemicals & Pharmaceuticals Limited's stock price Rs2192.80 by its total outstanding shares 160558706 (160.56 Million). Review how much debt does JB Chemicals & Pharmaceuticals Limited carry to assess the company's total debt and financial obligations.
JB Chemicals & Pharmaceuticals Limited Market Cap History: 2015 to 2026
JB Chemicals & Pharmaceuticals Limited's market capitalization history from 2015 to 2026. Data shows growth from $216.85 Million to $3.81 Billion (30.02% CAGR).
Index Memberships
JB Chemicals & Pharmaceuticals Limited is a constituent of 6 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY PHARMA
CNXPHARMA
|
$91.62 Billion | 4.16% | #11 of 20 |
|
NIFTY 500
NIFTY500
|
$3.11 Trillion | 0.12% | #172 of 500 |
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$1.14 Trillion | 0.34% | #98 of 400 |
|
NIFTY MNC
NIFTYMNC
|
$231.03 Billion | 1.65% | #16 of 30 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.20 Trillion | 0.12% | #170 of 750 |
|
NIFTY SMALLCAP 250
NISM250
|
$385.45 Billion | 0.99% | #13 of 250 |
Weight: JB Chemicals & Pharmaceuticals Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
JB Chemicals & Pharmaceuticals Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how JB Chemicals & Pharmaceuticals Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.09x
JB Chemicals & Pharmaceuticals Limited's market cap is 0.09 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.54x
JB Chemicals & Pharmaceuticals Limited's market cap is 0.54 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $270.37 Million | $13.09 Billion | $1.84 Billion | 0.02x | 0.15x |
| 2018 | $244.74 Million | $13.82 Billion | $1.38 Billion | 0.02x | 0.18x |
| 2019 | $346.07 Million | $16.08 Billion | $1.93 Billion | 0.02x | 0.18x |
| 2020 | $846.34 Million | $17.41 Billion | $2.72 Billion | 0.05x | 0.31x |
| 2021 | $1.49 Billion | $20.19 Billion | $4.48 Billion | 0.07x | 0.33x |
| 2022 | $1.64 Billion | $24.24 Billion | $3.85 Billion | 0.07x | 0.43x |
| 2023 | $2.79 Billion | $31.17 Billion | $4.10 Billion | 0.09x | 0.68x |
| 2024 | $3.20 Billion | $34.48 Billion | $5.53 Billion | 0.09x | 0.58x |
| 2025 | $3.16 Billion | $38.62 Billion | $6.60 Billion | 0.08x | 0.48x |
| 2026 | $3.81 Billion | $41.48 Billion | $7.09 Billion | 0.09x | 0.54x |
Competitor Companies of JBCHEPHARM by Market Capitalization
Companies near JB Chemicals & Pharmaceuticals Limited in the global market cap rankings as of June 17, 2026.
Key companies related to JB Chemicals & Pharmaceuticals Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #513 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #561 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #624 globally with a market cap of $44.20 Billion USD ( CN¥302.05 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #513 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #561 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.22 |
| #624 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $44.20 Billion | CN¥47.35 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.60 |
JB Chemicals & Pharmaceuticals Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, JB Chemicals & Pharmaceuticals Limited's market cap moved from $216.85 Million to $ 3.81 Billion, with a yearly change of 30.02%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs3.81 Billion | +20.50% |
| 2025 | Rs3.16 Billion | -1.33% |
| 2024 | Rs3.20 Billion | +14.63% |
| 2023 | Rs2.79 Billion | +70.21% |
| 2022 | Rs1.64 Billion | +9.90% |
| 2021 | Rs1.49 Billion | +76.45% |
| 2020 | Rs846.34 Million | +144.56% |
| 2019 | Rs346.07 Million | +41.40% |
| 2018 | Rs244.74 Million | -9.48% |
| 2017 | Rs270.37 Million | -3.35% |
| 2016 | Rs279.73 Million | +29.00% |
| 2015 | Rs216.85 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of JB Chemicals & Pharmaceuticals Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.81 Billion USD |
| MoneyControl | $3.81 Billion USD |
| MarketWatch | $3.81 Billion USD |
| marketcap.company | $3.81 Billion USD |
| Reuters | $3.81 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About JB Chemicals & Pharmaceuticals Limited
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; and nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dos… Read more